Literature DB >> 18306329

Long-term, tumor-free survival after radiotherapy combining hepatectomy-Whipple en bloc and orthotopic liver transplantation for early-stage hilar cholangiocarcinoma.

Youmin Wu1, Frederick C Johlin, Stephen C Rayhill, Chris S Jensen, Jin Xie, Michael B Cohen, Frank A Mitros.   

Abstract

This retrospective study reviews our experience in surveillance and early detection of cholangiocarcinoma (CC) and in using en bloc total hepatectomy-pancreaticoduodenectomy-orthotopic liver transplantation (OLT-Whipple) to achieve complete eradication of early-stage CC complicating primary sclerosing cholangitis (PSC). Asymptomatic PSC patients underwent surveillance using endoscopic ultrasound and endoscopic retrograde cholangiopancreatography (ERCP) with multilevel brushings for cytological evaluation. Patients diagnosed with CC were treated with combined extra-beam radiotherapy, lesion-focused brachytherapy, and OLT-Whipple. Between 1988 and 2001, 42 of 119 PSC patients were followed according to the surveillance protocol. CC was detected in 8 patients, 6 of whom underwent OLT-Whipple. Of those 6 patients, 4 had stage I CC, and 2 had stage II CC. All 6 OLT-Whipple patients received combined external-beam and brachytherapy radiotherapy. The median time from diagnosis to OLT-Whipple was 144 days. One patient died 55 months post-transplant of an unrelated cause, without tumor recurrence. The other 5 are well without recurrence at 5.7, 7.0, 8.7, 8.8, and 10.1 years. In conclusion, for patients with PSC, ERCP surveillance cytology and intralumenal endoscopic ultrasound examination allow for early detection of CC. Broad and lesion-focused radiotherapy combined with OLT-Whipple to remove the biliary epithelium en bloc offers promising long-term, tumor-free survival. All patients tolerated this extensive surgery well with good quality of life following surgery and recovery. These findings support consideration of the complete excision of an intact biliary tree via OLT-Whipple in patients with early-stage hilar CC complicating PSC.

Entities:  

Mesh:

Year:  2008        PMID: 18306329     DOI: 10.1002/lt.21287

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  8 in total

Review 1.  [Liver transplantation for hilar cholangiocarcinoma].

Authors:  F Rauchfuss; F Utess; S Schüle; Y Dittmar; H Scheuerlein; U Settmacher
Journal:  Chirurg       Date:  2012-03       Impact factor: 0.955

Review 2.  Liver transplantation for hilar cholangiocarcinoma.

Authors:  Ricardo Robles; Francisco Sánchez-Bueno; Pablo Ramírez; Roberto Brusadin; Pascual Parrilla
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

Review 3.  External radiotherapy and brachytherapy in the management of extrahepatic and intrahepatic cholangiocarcinoma: available evidence.

Authors:  Puja Sahai; Senthil Kumar
Journal:  Br J Radiol       Date:  2017-05-23       Impact factor: 3.039

4.  Pancreaticoduodenectomy after liver transplantation in patients with primary sclerosing cholangitis complicated by distal pancreatobiliary malignancy.

Authors:  Robert P Sutcliffe; Wayne Lam; Adrian O'Sullivan; Andreas Prachalias; Mohamed Rela; Nigel Heaton
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

5.  [Hepatocellular carcinoma and cholangiocarcinoma].

Authors:  F Rauchfuss; H Scheuerlein; M Götz; Y Dittmar; R Voigt; M Heise; U Settmacher
Journal:  Chirurg       Date:  2010-10       Impact factor: 0.955

Review 6.  Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management.

Authors:  Sumera Rizvi; John E Eaton; Gregory J Gores
Journal:  Clin Gastroenterol Hepatol       Date:  2015-06-05       Impact factor: 11.382

7.  Neoadjuvant chemoradiotherapy followed by liver transplantation is a promising treatment for patients with unresectable hilar cholangiocarcinoma: A case report.

Authors:  Jun Wang; Halmurat Obulkasim; Xiaoping Zou; Baorui Liu; Yafu Wu; Xingyu Wu; Yitao Ding
Journal:  Oncol Lett       Date:  2018-12-28       Impact factor: 2.967

8.  Systemic Venous Inflow to the Liver Allograft to Overcome Diffuse Splanchnic Venous Thrombosis.

Authors:  Cristian Lupascu; Tom Darius; Pierre Goffette; Jan Lerut
Journal:  Gastroenterol Res Pract       Date:  2015-10-11       Impact factor: 2.260

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.